Spero Therapeutics

Stundick joins Spero Therapeutics

Friday, January 22, 2016

Spero Therapeutics, a biopharmaceutical company founded to develop novel therapies for the treatment of bacterial infections, has announced the appointment of Melissa Stundick, Ph.D., to the newly created leadership position of head of Strategic Alliances.

[Read More]